Polimorfismos para predecir o pronosticar la respuesta al tratamiento antiviral

摘要

The invention relates to a method for obtaining useful data for predicting or forecasting the response to antiviral treatment with pegylated interferon and ribavirin in patients with chronic hepatitis C genotype 1, presenting the allele HLA-DQB1*0301. The invention also relates to the kit or device and to the uses thereof.